PSTV
PLUS THERAPEUTICS, Inc. Common Stock
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
PLUS THERAPEUTICS (PSTV) Stock: Buy, Sell, or Hold?
$3.87
+0.22 (+6.03%)
▲
5d:
+1.04%
30d:
-6.97%
90d:
-36.97%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (75%)
Quality Score
53/100
Position
FAIR
Forward P/E & Valuation
-1.6x
Next 12M consensus est.
Wall Street Target
$36.00
+830.2% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$3.55 / $4.08
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: PSTV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When PSTV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: PSTV is currently trading at $3.87, which is considered fair based on recent price action.
Technical Outlook: Technically, PSTV is in a strong uptrend. Immediate support is located at $3.55, while resistance sits at $4.08. The stock is showing strong short-term momentum, up 6.0% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $36.00 (+830.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PSTV is in a strong uptrend. Immediate support is located at $3.55, while resistance sits at $4.08. The stock is showing strong short-term momentum, up 6.0% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $36.00 (+830.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
53/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
74.7%
Trading Range & Key Levels
Support Level
$3.55
Resistance Level
$4.08
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: Strong upward momentum (+6.0%)
- BULLISH: Trading 830.2% below Wall St target ($36.00)
- NEUTRAL: Bottoming setup forming (45/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
-1.62
Wall Street Target
$36.00
(+830.2%)
Revenue Growth (YoY)
-2.9%
Profit Margin
-230.2%
Share PSTV Analysis
Share this live PSTV analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PSTV)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jul 31, 2026
Daily AI digest
AI Retail Discussion Summary:
Cerenome announces rebrand and integration of diagnostics, therapeutics, and AI for CNS oncology
Key Retail Themes:
company rebrand
integration of diagnostics, therapeutics, and AI
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 12:21 AM ET
Data refreshes hourly during market hours. Next update: 1:21 AM
Data refreshes hourly during market hours. Next update: 1:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PSTV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 32 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PSTV Research Pages
